FDA recall D-0085-2023

SUN PHARMACEUTICAL INDUSTRIES INC · Class II · drug

Product

Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India.

Reason for recall

Presence of foreign substance

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2022-12-01
Report date
2022-12-28
Termination date
2023-09-13
Voluntary/Mandated
Voluntary: Firm initiated
Location
Princeton, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0085-2023